Please assess the completion status of the following clinical trial:

Trial Title: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven stage II-IV adenocarcinoma of the stomach including cardia carcinoma types II and III~  * Locally resectable disease~ * No distant metastases except M1 lymph nodes~ * No evidence of peritoneal carcinomatosis~    * Free tumor cells in lavage at laparoscopy allowed~* No uncontrolled bleeding of the primary tumor~* No gastric outlet syndrome or complete tumor stenosis that would require total parenteral nutrition~PATIENT CHARACTERISTICS:~Age:~* 18 to 69~Performance status:~* WHO 0-1~Life expectancy:~* Not specified~Hematopoietic:~* WBC greater than 4,000/mm\^3~* Absolute neutrophil count greater than 2,000/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic:~* Bilirubin no greater than 1.25 times upper limit of normal (ULN)~* Prothrombin rate at least 70%~Renal:~* Creatinine no greater than 1.25 times ULN~* Creatinine clearance greater than 60 mL/min~Cardiovascular:~* No prior atrial or ventricular arrhythmias~* No prior congestive heart failure~* No myocardial infarction within the past 6 months~Other:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* No other prior or concurrent neoplasm except curatively treated nonmelanoma skin cancer or carcinoma in situ of the cervix~* No active infection~* No allergy to protocol drugs~* No dementia or significantly altered mental status~* No other serious medical condition that would prevent compliance~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* No filgrastim (G-CSF) within 48 hours prior to chemotherapy~Chemotherapy:~* No prior chemotherapy~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy~Surgery:~* See Disease Characteristics~* No prior stent implantation~* No prior laser therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).